Boston Scientific Quick Ratio 2006-2018 | BSX

Historical quick ratio values for Boston Scientific (BSX) over the last 10 years.
Boston Scientific Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2018-12-31 $2.84B $5.26B 0.54
2018-09-30 $2.84B $5.08B 0.56
2018-06-30 $2.84B $4.75B 0.60
2018-03-31 $2.97B $4.99B 0.60
2017-12-31 $2.74B $5.65B 0.49
2017-09-30 $2.40B $4.83B 0.50
2017-06-30 $2.20B $4.30B 0.51
2017-03-31 $2.06B $3.49B 0.59
2016-12-31 $2.28B $3.59B 0.64
2016-09-30 $2.18B $3.02B 0.72
2016-06-30 $2.35B $3.18B 0.74
2016-03-31 $2.14B $2.61B 0.82
2015-12-31 $2.46B $2.43B 1.01
2015-09-30 $2.38B $2.24B 1.06
2015-06-30 $2.81B $1.94B 1.45
2015-03-31 $2.23B $2.46B 0.91
2014-12-31 $2.66B $2.85B 0.94
2014-09-30 $2.19B $1.82B 1.20
2014-06-30 $2.27B $1.77B 1.28
2014-03-31 $2.01B $1.72B 1.17
2013-12-31 $2.11B $1.82B 1.16
2013-09-30 $2.63B $1.90B 1.38
2013-06-30 $2.66B $2.48B 1.07
2013-03-31 $2.25B $1.64B 1.38
2012-12-31 $2.14B $1.77B 1.21
2012-09-30 $2.26B $1.82B 1.25
2012-06-30 $2.21B $1.79B 1.23
2012-03-31 $2.20B $1.67B 1.32
2011-12-31 $2.17B $1.81B 1.20
2011-09-30 $2.24B $1.89B 1.19
2011-06-30 $2.22B $1.89B 1.17
2011-03-31 $2.67B $2.04B 1.31
2010-12-31 $2.72B $2.61B 1.04
2010-09-30 $2.63B $2.96B 0.89
2010-06-30 $3.10B $3.72B 0.83
2010-03-31 $2.84B $2.91B 0.98
2009-12-31 $3.71B $3.02B 1.23
2009-09-30 $4.02B $3.18B 1.27
2009-06-30 $3.92B $2.75B 1.43
2009-03-31 $3.72B $2.43B 1.53
2008-12-31 $4.60B $3.23B 1.42
2008-09-30 $4.43B $3.54B 1.25
2008-06-30 $4.36B $3.04B 1.44
2008-03-31 $4.46B $3.39B 1.31
2007-12-31 $5.22B $3.25B 1.61
2007-09-30 $3.87B $3.38B 1.15
2007-06-30 $4.10B $2.97B 1.38
2007-03-31 $3.79B $2.37B 1.60
2006-12-31 $5.35B $2.63B 2.03
2006-09-30 $3.99B $2.45B 1.63
2006-06-30 $3.61B $2.17B 1.66
2006-03-31 $2.47B $2.04B 1.21
2005-12-31 $2.21B $1.48B 1.50
2005-09-30 $2.33B $1.14B 2.04
2005-06-30 $2.31B $1.76B 1.31
2005-03-31 $2.37B $1.78B 1.33
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $51.696B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29